PMC:7696151 / 44575-44825
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1247 | 62-70 | Species | denotes | patients | Tax:9606 |
| 1253 | 82-95 | Chemical | denotes | sulfasalazine | MESH:D012460 |
| 1254 | 100-103 | Chemical | denotes | HCQ | MESH:D006886 |
| 1255 | 127-130 | Chemical | denotes | HCQ | MESH:D006886 |
| 1256 | 207-220 | Chemical | denotes | sulfasalazine | MESH:D012460 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T290 | 0-250 | Sentence | denotes | Two comparative double-blind, randomized trials, involving 60 patients each, with sulfasalazine and HCQ have demonstrated that HCQ showed no significant differences among overall clinical effects respect to sulfasalazine, but presented a later onset. |